Citation Impact
Citing Papers
Phase I trial of temozolomide using an extended continuous oral schedule.
1998
Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant Temozolomide
2002
Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules
2003
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
2008 StandoutNature
No health without mental health
2007 Standout
Parental history is an independent risk factor for coronary artery disease: The Framingham Study
1990
Phase 1 trial of temozolomide plus irinotecan plus O6‐benzylguanine in adults with recurrent malignant glioma
2009
Regression of Coronary Artery Disease as a Result of Intensive Lipid-Lowering Therapy in Men with High Levels of Apolipoprotein B
1990 Standout
Quality assurance of the EORTC 26981/22981; NCIC CE3 intergroup trial on radiotherapy with or without temozolomide for newly-diagnosed glioblastoma multiforme: the individual case review
2004
Risk Factors for Cerebrovascular Disease as Correlates of Cognitive Function in a Stroke-Free Cohort
1993
Involvement of the TIP60 Histone Acetylase Complex in DNA Repair and Apoptosis
2000 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
Pentoxifylline
1987 Standout
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Obesity
2005 Standout
Diclofenac residues as the cause of vulture population decline in Pakistan
2004 StandoutNature
Genetic Susceptibility to Death from Coronary Heart Disease in a Study of Twins
1994
Cardiovascular Effects of n-3 Fatty Acids
1988 Standout
Temozolomide as an alternative to irradiation for elderly patients with newly diagnosed malignant gliomas
2003
The low density lipoprotein receptor
1989
Temozolomide: a review of its discovery, chemical properties, pre-clinical development and clinical trials
1997
The “All of Us” Research Program
2019 Standout
Malignant Gliomas in Adults
2008 Standout
An Antibody Fragment from a Phage Display Library Competes for Ligand Binding to the Low Density Lipoprotein Receptor Family and Inhibits Rhinovirus Infection
1995 StandoutNobel
Delayed repletion of O6-methylguanine—DNA methyltransferase resulting in failure to protect the human glioblastoma cell line SF767 from temozolomide-induced cytotoxicity
2003
Long-Term Complications of Diabetes Mellitus
1993 Standout
Current and future developments in the use of temozolomide for the treatment of brain tumours
2001
Obesity as a medical problem
2000 StandoutNature
Inverse‐electron‐demand Diels‐Alder reaction as a highly efficient chemoselective ligation procedure: Synthesis and function of a BioShuttle for temozolomide transport into prostate cancer cells
2009
Radiotherapy plus Concomitant and Adjuvant Temozolomide for Glioblastoma
2005 Standout
Cu-free click cycloaddition reactions in chemical biology
2010 StandoutNobel
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
2010 Standout
Atherosclerosis
2000 StandoutNature
Common Genetic Vulnerability to Depressive Symptoms and Coronary Artery Disease: A Review and Development of Candidate Genes Related to Inflammation and Serotonin
2006
Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians
1991
Hyperhomocysteinemia: An Independent Risk Factor for Vascular Disease
1991 Standout
Genetic Risk, Adherence to a Healthy Lifestyle, and Coronary Disease
2016
Brain Tumors
2001 Standout
Discovery of the cellular and molecular basis of cholesterol control
2013 StandoutNobel
Hippocampal atrophy in recurrent major depression.
1996 Standout
The inheritance of familial hypercholesterolemia
1972
Suppression of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity and Inhibition of Growth of Human Fibroblasts by 7-Ketocholesterol
1974 StandoutNobel
Prediction of Coronary Heart Disease Using Risk Factor Categories
1998 Standout
Women, work and coronary heart disease: prospective findings from the Framingham heart study.
1980
Esterification of Low Density Lipoprotein Cholesterol in Human Fibroblasts and Its Absence in Homozygous Familial Hypercholesterolemia
1974 StandoutNobel
Hyperlipidemia in Coronary Heart Disease II. GENETIC ANALYSIS OF LIPID LEVELS IN 176 FAMILIES AND DELINEATION OF A NEW INHERITED DISORDER, COMBINED HYPERLIPIDEMIA
1973 StandoutNobel
Familial hypercholesterolemia: Defective binding of lipoproteins to cultured fibroblasts associated with impaired regulation of 3-hydroxy-3-methylglutaryl coenzyme a reductase activity
1974 StandoutNobel
Relation between Complications of Type I Diabetes Mellitus and Collagen-Linked Fluorescence
1986 Standout
Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma
2000
Role of the low density lipoprotein receptor in regulating the content of free and esterified cholesterol in human fibroblasts.
1975 StandoutNobel
Regulation of Plasma Cholesterol by Lipoprotein Receptors
1981 StandoutScienceNobel
RISKS OF ISCHÆMIC HEART-DISEASE IN FAMILIAL HYPERLIPOPROTEINÆMIC STATES
1969
Family history of myocardial infarction as an independent risk factor for coronary heart disease.
1985
DNA Mismatch Repair: Functions and Mechanisms
2005 StandoutNobel
Hyperlipidemia in Coronary Heart Disease III. EVALUATION OF LIPOPROTEIN PHENOTYPES OF 156 GENETICALLY DEFINED SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
A Receptor-Mediated Pathway for Cholesterol Homeostasis
1986 StandoutScienceNobel
LIPID ABNORMALITIES IN MALE AND FEMALE SURVIVORS OF MYOCARDIAL INFARCTION AND THEIR FIRST-DEGREE RELATIVES
1972
Familial Hypercholesterolemia: Identification of a Defect in the Regulation of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Activity Associated with Overproduction of Cholesterol
1973 StandoutNobel
Genetic aspects of arteriosclerosis.
1986
NEONATAL DIAGNOSIS OF FAMILIAL TYPE-II HYPERLIPOPROTEINÆMIA
1973
Benefit of Temozolomide Compared to Procarbazine in Treatment of Glioblastoma Multiforme at First Relapse: Effect on Neurological Functioning, Performance Status, and Health Related Quality of Life
2005
Effect of oral administration of highly purified eicosapentaenoic acid on platelet function, blood viscosity and red cell deformability in healthy human subjects
1983
Some difficulties in the investigation of genetic factors in coronary artery disease.
1967
Homozygous familial hypercholesterolemia: specificity of the biochemical defect in cultured cells and feasibility of prenatal detection.
1974 StandoutNobel
Impaired erythrocyte doublet formation in diabetes
1981
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
Fine-Particulate Air Pollution and Life Expectancy in the United States
2009 Standout
Genetics of Common Disorders
1969
Genetic Dissection of Complex Traits
1994 StandoutScience
A Bioorthogonal Quadricyclane Ligation
2011 StandoutNobel
Regulation of 3-Hydroxy-3-methylglutaryl Coenzyme A Reductase Activity in Cultured Human Fibroblasts
1974 StandoutNobel
FAMILY STUDY OF SERUM LIPIDS AND LIPOPROTEINS IN CORONARY HEART-DISEASE
1973
Familial Hypercholesterolemia in a Large Kindred
1972 StandoutNobel
Heterozygous familial hypercholesterolemia: Failure of normal allele to compensate for mutant allele at a regulated genetic locus
1976 StandoutNobel
Familial hypercholesterolemia
1975 StandoutNobel
Environmental Cardiology
2006
Plasma and Cerebrospinal Fluid Population Pharmacokinetics of Temozolomide in Malignant Glioma Patients
2004
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
Receptor-Mediated Control of Cholesterol Metabolism
1976 StandoutScienceNobel
PREVENTION OF DETERIORATION OF RENAL AND SENSORY-NERVE FUNCTION BY MORE INTENSIVE MANAGEMENT OF INSULIN-DEPENDENT DIABETIC PATIENTS
1983
Hyperlipidemia in Coronary Heart Disease I. LIPID LEVELS IN 500 SURVIVORS OF MYOCARDIAL INFARCTION
1973 StandoutNobel
hMutSα- and hMutLα-dependent phosphorylation of p53 in response to DNA methylator damage
1999 StandoutNobel
Family history of heart attack as an independent predictor of death due to cardiovascular disease.
1984
Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First Relapse
1999
Correlation of O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation With Clinical Outcomes in Glioblastoma and Clinical Strategies to Modulate MGMT Activity
2008
Involvement of the Mismatch Repair System in Temozolomide-Induced Apoptosis
1998
Expression of the Familial Hypercholesterolemia Gene in Heterozygotes: Mechanism for a Dominant Disorder in Man
1974 StandoutScienceNobel
Human Aging: Usual and Successful
1987 StandoutScience
Binding and Degradation of Low Density Lipoproteins by Cultured Human Fibroblasts
1974 StandoutNobel
Isolation and sequence of a human apolipoprotein CII cDNA clone and its use to isolate and map to human chromosome 19 the gene for apolipoprotein CII.
1984
Works of J. Slack being referenced
Phase I trial of temozolomide (CCRG 81045: M&B 39831: NSC 362856)
1992
Lipid and lipoprotein concentrations in 1604 men and women in working populations in north-west London.
1977
GENETICS OF HYPERLIPOPROTEINÆMIAS
1971
The Increased Risk of Death from Ischaemic Heart Disease in First Degree Relatives of 121 Men and 96 Women with Ischaemic Heart Disease
1966
Hyperlipidaemic xanthomatosis. II. Mode of inheritance in 55 families with essential hyperlipidaemia and xanthomatosis.
1968
Familial apolipoprotein CII deficiency: plasma lipoproteins and apolipoproteins in heterozygous and homozygous subjects and the effects of plasma infusion
1981
IS HYPERVISCOSITY A TREATABLE COMPONENT OF DIABETIC MICROCIRCULATORY DISEASE?
1977
Hyperlipidaemic xanthomatosis. I. Increased risk of death from ischaemic heart disease in first degree relatives of 53 patients with essential hyperlipidaemia and xanthomatosis.
1968